Lipella Pharmaceuticals Stock Forward View
| LIPO Stock | 0.21 0.01 4.55% |
Lipella Stock outlook is based on your current time horizon. Although Lipella Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Lipella Pharmaceuticals' systematic risk associated with finding meaningful patterns of Lipella Pharmaceuticals fundamentals over time.
As of today, the RSI of Lipella Pharmaceuticals' share price is approaching 47. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Lipella Pharmaceuticals, making its price go up or down. Momentum 47
Impartial
Oversold | Overbought |
Wall Street Target Price 10 | Quarterly Revenue Growth (0.36) |
Using Lipella Pharmaceuticals hype-based prediction, you can estimate the value of Lipella Pharmaceuticals Common from the perspective of Lipella Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Lipella Pharmaceuticals Common on the next trading day is expected to be 0.25 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.71. Lipella Pharmaceuticals after-hype prediction price | USD 0.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Lipella Pharmaceuticals to cross-verify your projections. Lipella Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Lipella price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lipella using various technical indicators. When you analyze Lipella charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Lipella Pharmaceuticals Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Lipella Pharmaceuticals' financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2010-12-31 | Previous Quarter 2.5 M | Current Value 2.3 M | Quarterly Volatility 1.5 M |
Lipella Pharmaceuticals Naive Prediction Price Forecast For the 5th of February
Given 90 days horizon, the Naive Prediction forecasted value of Lipella Pharmaceuticals Common on the next trading day is expected to be 0.25 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.71.Please note that although there have been many attempts to predict Lipella Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Lipella Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Lipella Pharmaceuticals Stock Forecast Pattern
| Backtest Lipella Pharmaceuticals | Lipella Pharmaceuticals Price Prediction | Research Analysis |
Lipella Pharmaceuticals Forecasted Value
In the context of forecasting Lipella Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Lipella Pharmaceuticals' downside and upside margins for the forecasting period are 0 and 13.94, respectively. We have considered Lipella Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Lipella Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Lipella Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.3969 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.028 |
| MAPE | Mean absolute percentage error | 0.1 |
| SAE | Sum of the absolute errors | 1.706 |
Predictive Modules for Lipella Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lipella Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Lipella Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Lipella Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lipella Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Lipella Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Lipella Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Lipella Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lipella Pharmaceuticals' historical news coverage. Lipella Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.01 and 13.91, respectively. We have considered Lipella Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Lipella Pharmaceuticals is extremely dangerous at this time. Analysis and calculation of next after-hype price of Lipella Pharmaceuticals is based on 3 months time horizon.
Lipella Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Lipella Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lipella Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lipella Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.05 | 13.69 | 0.00 | 0.00 | 0 Events / Month | 7 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.21 | 0.22 | 0.00 |
|
Lipella Pharmaceuticals Hype Timeline
Lipella Pharmaceuticals is now traded for 0.21. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Lipella is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at -0.05%. %. The volatility of related hype on Lipella Pharmaceuticals is about 19557.14%, with the expected price after the next announcement by competition of 0.21. The company has price-to-book ratio of 0.53. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Lipella Pharmaceuticals recorded a loss per share of 3.33. The entity had not issued any dividends in recent years. The firm had 1:8 split on the 8th of November 2024. Given the investment horizon of 90 days the next projected press release will be uncertain. Check out Historical Fundamental Analysis of Lipella Pharmaceuticals to cross-verify your projections.Lipella Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Lipella Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Lipella Pharmaceuticals' future price movements. Getting to know how Lipella Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lipella Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PTIX | Protagenic Therapeutics | 0.17 | 4 per month | 0.00 | (0.20) | 14.81 | (15.25) | 58.73 | |
| GTBP | GT Biopharma | 0.02 | 9 per month | 0.00 | (0.02) | 10.84 | (11.96) | 51.03 | |
| AZTR | Azitra Inc | 0.01 | 6 per month | 0.00 | (0.12) | 7.14 | (11.36) | 36.11 | |
| ARTL | Artelo Biosciences | (0.03) | 10 per month | 0.00 | (0.12) | 7.86 | (11.25) | 41.63 | |
| NKGN | NKGen Biotech Common | (0.15) | 20 per month | 0.00 | 0.21 | 20.00 | (6.00) | 68.90 | |
| SLRX | Salarius Pharmaceuticals | (0.02) | 6 per month | 0.00 | (0.19) | 16.00 | (16.92) | 61.05 | |
| DRMA | Dermata Therapeutics | (0.15) | 8 per month | 0.00 | (0.06) | 16.18 | (16.23) | 61.86 | |
| VRAX | Virax Biolabs Group | 0.01 | 7 per month | 0.00 | (0.07) | 7.89 | (10.20) | 92.80 | |
| INDP | Indaptus Therapeutics | (0.09) | 9 per month | 0.00 | (0.06) | 13.58 | (12.56) | 51.64 | |
| PBM | Psyence Biomedical Ltd | (0.47) | 10 per month | 0.00 | (0.24) | 9.41 | (13.89) | 96.64 |
Other Forecasting Options for Lipella Pharmaceuticals
For every potential investor in Lipella, whether a beginner or expert, Lipella Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Lipella Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Lipella. Basic forecasting techniques help filter out the noise by identifying Lipella Pharmaceuticals' price trends.Lipella Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lipella Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Lipella Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Lipella Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Lipella Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Lipella Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lipella Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Lipella Pharmaceuticals stock market strength indicators, traders can identify Lipella Pharmaceuticals Common entry and exit signals to maximize returns.
Lipella Pharmaceuticals Risk Indicators
The analysis of Lipella Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lipella Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lipella stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.92 | |||
| Standard Deviation | 13.19 | |||
| Variance | 174.02 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Lipella Pharmaceuticals
The number of cover stories for Lipella Pharmaceuticals depends on current market conditions and Lipella Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lipella Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lipella Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Lipella Pharmaceuticals Short Properties
Lipella Pharmaceuticals' future price predictability will typically decrease when Lipella Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lipella Pharmaceuticals Common often depends not only on the future outlook of the potential Lipella Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lipella Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1 M | |
| Cash And Short Term Investments | 2.2 M |
Check out Historical Fundamental Analysis of Lipella Pharmaceuticals to cross-verify your projections. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Will Biotechnology sector continue expanding? Could Lipella diversify its offerings? Factors like these will boost the valuation of Lipella Pharmaceuticals. Expected growth trajectory for Lipella significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Lipella Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (3.33) | Revenue Per Share | Quarterly Revenue Growth (0.36) | Return On Assets | Return On Equity |
The market value of Lipella Pharmaceuticals is measured differently than its book value, which is the value of Lipella that is recorded on the company's balance sheet. Investors also form their own opinion of Lipella Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Lipella Pharmaceuticals' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Lipella Pharmaceuticals' market value can be influenced by many factors that don't directly affect Lipella Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Lipella Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Lipella Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Lipella Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.